News
-
-
PRESS RELEASE
Enveric Biosciences Signs $66.5 Million Non-Binding Term Sheet with MindBio Therapeutics to Out-License Novel Psilocin Prodrug Candidate for Mental Health Disorders
MindBio to develop novel psilocin prodrug from Enveric Biosciences for neuropsychiatric indications, utilizing microdosing to minimize hallucinogenic effects of psychedelic compounds -
-
PRESS RELEASE
MindBio Therapeutics Scientists Present Landmark Women’s Health Trials. Company To Release Phase 2A Depression Trial Secondary Data This Month
MindBio Therapeutics Corp. showcases women's health trials and upcoming data presentation on Phase 2A trial of MB22001 for Major Depressive Disorder. Company pioneering microdosing LSD for mental health conditions -
-
PRESS RELEASE
MindBio Is Exploring Dual Listing on A Senior Exchange with Multiple Phase 2B Clinical Trials Underway Supported by Positive Trial Data and Planning for Phase 3
MindBio announces successful completion of Phase 1 and Phase 2a Clinical Trials for MB22001 in treating Major Depressive Disorder. Company plans dual listing on senior exchange -
-
-
-
PRESS RELEASE
MindBio Landmark Sleep Research Published in Prestigious Nature Portfolio Journal Translational Psychiatry
MindBio's sleep research using MB22001 published in Nature's Translational Psychiatry journal. Research indicates improved sleep quality & duration after microdosing, advancing treatment for depressive disorders globally
-
Wood in Architecture Awards Celebrate Innovative & Resilient Design
-
PPX Mining Completes Debt Settlement Transaction
-
Arras Minerals Closes C$5.2 Million Non-Brokered Financing
-
Aston Bay Holdings Closes $2,137,860 Second Tranche of Non-Brokered Private Placement for $3,517,860 Total to Date
-
Apex Critical Metals Corp. Signs Earn-In Agreement with Discovery Lithium & DG Resource Management
-
Patrimonium Swiss Real Estate Fund: stable results in a difficult environment
-
Molten Ventures Plc: HOL-Holding(s) in Company
-
Eighteenth Annual General Meeting of Delticom AG
-
Annual General Meeting of CANCOM SE elects Supervisory Board and approves dividend of € 1.00
-
PNE AG successfully sells its US division to Lotus Infrastructure Partners
-
Shareholders’ Meeting and Board of Directors’ meeting on June 6, 2024
-
Disclosure of voting rights - 06.06.2024
-
Eurazeo announces the signing by Grape Hospitality of an exclusivity agreement for the sale of 23 hotels
-
Safran: Update on proposed acquisition of Collins Aerospace’s actuation and flight control business
-
Aéroports de Paris SA - Voting rights as of 31 May 2024